All Stories

  1. Mitochondrial Dysfunction Associated with mtDNA Mutation: Mitochondrial Genome Editing in Atherosclerosis Research

    Article • Current Medicinal Chemistry, February 2026, Bentham Science Publishers

    Vasily N Sukhorukov, Alexander Orekhov

  2. Lipid-Lowering Therapies for Atherosclerosis: Statins, Fibrates, Ezetimibe and PCSK9 Monoclonal Antibodies

    Article • Current Medicinal Chemistry, November 2021, Bentham Science Publishers

    HADI YASSINE, Kazem Zibara, Alexander Orekhov, Adel Hajj Ali

  3. Genetic and Epigenetic Biomarkers for Diagnosis, Prognosis and Treatment of Metabolic Syndrome

    Article • Current Pharmaceutical Design, October 2021, Bentham Science Publishers

    Prof Marcello Ciaccio, anca mihaela PANTEA STOIAN, Vasily N Sukhorukov, Alexander Orekhov

  4. Mutations of mtDNA in some Vascular and Metabolic Diseases

    Article • Current Pharmaceutical Design, February 2021, Bentham Science Publishers

    Alexander Orekhov, Dr Margarita A Sazonova

  5. Do Mitochondrial DNA Mutations Play a Key Role in the Chronification of Sterile Inflammation? Special Focus on Atherosclerosis

    Article • Current Pharmaceutical Design, February 2021, Bentham Science Publishers

    Alexander Orekhov

  6. Modern Concepts of Molecular Biology in Search of Biomarkers for Laboratory Diagnostics and Drug Therapy of Non-infectious Diseases

    Article • Current Pharmaceutical Design, February 2021, Bentham Science Publishers

    Alexander Orekhov

  7. Novel Approaches to Anti-atherosclerotic Therapy: Cell-based Models and Herbal Preparations (Review of Our Own Data)

    Article • Current Drug Discovery Technologies, July 2020, Bentham Science Publishers

    Alexander Orekhov, Dr Dongwei Zhang, Professor Dimitry A Chistiakov

  8. Modified LDL Particles Activate Inflammatory Pathways in Monocyte-derived Macrophages: Transcriptome Analysis

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Alexander Orekhov

  9. Translation of Basic Research into Clinical Practice: Focus on Cell-Based Diagnostics and Therapy

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Vasily N Sukhorukov, Alexander Orekhov

  10. Diagnostics and Therapy of Human Diseases - Focus on Sialidases

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Vasily N Sukhorukov, Alexander Orekhov

  11. Current Approaches to Diagnostics and Therapies of Chronic Diseases: Focus on Molecular and Cell Biology

    Article • Current Pharmaceutical Design, November 2018, Bentham Science Publishers

    Alexander Orekhov, Vasily N Sukhorukov

  12. Mitochondrial diseases caused by mtDNA mutations: a mini-review

    Article • Therapeutics and Clinical Risk Management, October 2018, Dove Medical Press

    Dr Margarita A Sazonova, Mariia Chicheva, Tatyana Shkurat, Alexander Orekhov

  13. Inhibition of sialidase activity as a therapeutic approach

    Article • Drug Design Development and Therapy, October 2018, Dove Medical Press

    Alexander Orekhov

  14. Role of androgens in cardiovascular pathology

    Article • Vascular Health and Risk Management, October 2018, Dove Medical Press

    Professor Dimitry A Chistiakov, Alexander Orekhov

  15. Engineered Nanoparticles: Their Properties and Putative Applications for Therapeutic Approaches Utilizing Stem Cells for the Repair of Atherosclerotic Disease

    Article • Current Drug Targets, September 2018, Bentham Science Publishers

    Professor Dimitry A Chistiakov, Alexander Orekhov

  16. Response to: Comment on “Role of Mitochondrial Genome Mutations in Pathogenesis of Carotid Atherosclerosis”

    Article • Oxidative Medicine and Cellular Longevity, August 2018, Hindawi Publishing Corporation

    Dr Margarita A Sazonova, Tatyana Shkurat, Alexander Orekhov

  17. Mutations of Nuclear and Mitochondrial Genomes as Potential Targets for the Treatment of Metabolic Syndrome

    Article • Current Pharmaceutical Design, July 2018, Bentham Science Publishers

    Alexander Orekhov

  18. Cybrid Models of Pathological Cell Processes in Different Diseases

    Article • Oxidative Medicine and Cellular Longevity, June 2018, Hindawi Publishing Corporation

    Dr Margarita A Sazonova, Alexander Orekhov

  19. Phytotherapy for the Prevention of Atherosclerosis-Associated Early Cerebral Ischemia

    Article • Current Drug Metabolism, May 2018, Bentham Science Publishers

    Alexander Orekhov

  20. Chemokines and Relevant microRNAs in the Atherogenic Process

    Article • Mini-Reviews in Medicinal Chemistry, March 2018, Bentham Science Publishers

    Professor Dimitry A Chistiakov, Alexander Orekhov

  21. Mitochondrial genome variability: the effect on cellular functional activity

    Article • Therapeutics and Clinical Risk Management, February 2018, Dove Medical Press

    Alexander Orekhov

  22. Mitochondrial Genome Mutations Associated with Myocardial Infarction

    Article • Disease Markers, January 2018, Hindawi Publishing Corporation

    Dr Margarita A Sazonova, Tatyana Shkurat, Alexander Orekhov

  23. Sialidases: Therapeutic and Antiatherogenic Potential

    Article • Current Pharmaceutical Design, December 2017, Bentham Science Publishers

    Mr Emile R Zakiev, Vasily N Sukhorukov, Alexander Orekhov

  24. Role of Mitochondrial Genome Mutations in Pathogenesis of Carotid Atherosclerosis

    Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

    Dr Margarita A Sazonova, Alexander Orekhov

  25. Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases

    Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

    Veronika Myasoedova, Alexander Orekhov

  26. Calcifying Matrix Vesicles and Atherosclerosis

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Veronika Myasoedova, Alexander Orekhov

  27. Carbohydrate composition of circulating multiple-modified low-density lipoprotein

    Article • Vascular Health and Risk Management, October 2016, Dove Medical Press

    Vasily N Sukhorukov, Mr Emile R Zakiev, Alexander Orekhov

  28. Editorial (Thematic Issue: The Crosstalk between Non-Pharmaceutical and Pharmaceutical Approaches to Prevention and Treatment of Chronic Diseases: Current Concepts and Perspectives)

    Article • Current Pharmaceutical Design, December 2015, Bentham Science Publishers

    Alexander Orekhov

  29. Editorial (Thematic Issue: Mechanistic Biomarkers: The Field for the Development of Non-Pharmaceutical and Pharmaceutical Approaches to Diagnostics, Prevention and Treatment of Chronic Diseases)

    Article • Current Pharmaceutical Design, December 2015, Bentham Science Publishers

    Alexander Orekhov

  30. LDL electronegativity index: a potential novel index for predicting cardiovascular disease

    Article • Vascular Health and Risk Management, August 2015, Dove Medical Press

    Alexander Orekhov

  31. Macrophages in Immunopathology of Atherosclerosis: A Target for Diagnostics and Therapy

    Article • Current Pharmaceutical Design, January 2015, Bentham Science Publishers

    Alexander Orekhov

  32. Editorial (Thematic Issue: Mechanisms of Atherogenesis and Development of Anti-Atherosclerotic Therapy)

    Article • Current Pharmaceutical Design, January 2015, Bentham Science Publishers

    Alexander Orekhov

  33. Direct Anti-Atherosclerotic Therapy; Development of Natural Anti-Atherosclerotic Drugs Preventing Cellular Cholesterol Retention

    Article • Current Pharmaceutical Design, August 2013, Bentham Science Publishers

    Alexander Orekhov